Scott Bienenfeld

Scott Bienenfeld, MD, is a highly experienced medical professional specializing in addiction psychiatry, general psychiatry, and forensic psychiatry. Currently serving as Co-Medical Director at Skylight Psychedelics since June 2022, Scott Bienenfeld focuses on advancing treatment options for patients with treatment-resistant conditions through innovative certification courses in ketamine treatment and psychedelic medicine. As Medical Director at PsychMed, since June 2019, Scott Bienenfeld oversees ketamine infusions for treatment-resistant depression and PTSD. Additionally, Scott Bienenfeld is the owner of Rebound New York Medical and Scott Bienenfeld, MD LLC, providing dedicated psychiatric care since 2003. Former roles include Medical Director and CEO of Rebound Brooklyn Outpatient Program and a Medical Director position at the New York Center for Living. Scott Bienenfeld earned an MD from Hahnemann University School of Medicine and holds a BA in Psychology from Dartmouth College.